Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06258837 · ClinicalTrials.gov registry record · NA

Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Small Tonsils

A NA study of Obstructive Sleep Apnea and Otolaryngological Disease, sponsored by Oregon Health and Science University.

Recruiting
Registry status
NA
Development phase
240
Enrollment target
2
Study locations

NCT06258837: Recruiting NA study of Obstructive Sleep Apnea and Otolaryngological Disease, sponsored by Oregon Health and Science University.

NCT06258837 is a NA study of Obstructive Sleep Apnea and Otolaryngological Disease that is actively recruiting participants, run by Oregon Health and Science University. The registered enrollment target is 240 participants, roughly in line with the 220-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target. The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06258837, a NA study of Obstructive Sleep Apnea and Otolaryngological Disease, is actively recruiting participants, sponsored by Oregon Health and Science University.

RECRUITING
Registry status
NA
Development phase
240 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this study is to compare the effectiveness of a novel personalized surgical approach to the standard AT in children with small tonsils (ST). This will be accomplished by randomizing children with ST and OSA to one of these two treatments and comparing outcomes after 6 months. It is the investigators' central hypothesis that a personalized drug-induced sleep endoscopy (DISE)-directed surgical approach that uses existing procedures to address the specific fixed and dynamic anatomic features causing obstruction (ie, anatomic endotypes) in each child with ST will perform better than the currently recommended standard first line approach of AT. This novel approach may improve OSA outcomes and reduce the burden of unnecessary AT or secondary surgery for persistent OSA after an ineffective AT. To test this hypothesis, the investigators propose to study children aged 2-17 years with small tonsils and OSA.

Primary Outcome

Objective results from sleep studies (polysomnography): Obstructive Apnea-Hypopnea Index (oAHI): 6 months follow up sleep study difference from baseline sleep study. Higher scores indicate higher disease burden. Scores can range from zero to two hundred.

Interventions

  • PROCEDURE DISE-Directed Surgery
  • PROCEDURE Adenotonsillectomy

Study Locations (2)

Michigan

  • University of Michigan - Ann Arbor

Oregon

  • Oregon Health and Science University - Portland

Trial Details

FieldValue
Enrollment Target 240 participants
Start Date 2024-10-04
Est. Completion 2028-09-30
Phase NA

What NCT06258837 shows while recruiting

NCT06258837 is an interventional study that assigns participants to a tested intervention. The registered 240 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 220-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target.

The record links to 2 conditions, with Obstructive Sleep Apnea appearing as the primary indexed condition, and to 2 interventions - of which DISE-Directed Surgery is the first listed.

NCT06258837 reports a single indexed study location in Michigan, Oregon.

Frequently Asked Questions

What is clinical trial NCT06258837 about?

NCT06258837 is a clinical study titled "Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Small Tonsils". The purpose of this study is to compare the effectiveness of a novel personalized surgical approach to the standard AT in children with small tonsils (ST). This will be accomplished by randomizing children with ST and OSA to one of these two treatments and comparing outcomes after 6 months. It is th...

What is the current status of trial NCT06258837?

This trial is currently recruiting. It is a NA study. The enrollment target is 240 participants. The study started on 2024-10-04. Estimated completion is 2028-09-30.

What conditions does trial NCT06258837 study?

This clinical trial studies the following conditions: Obstructive Sleep Apnea, Otolaryngological Disease.

What interventions are being tested in trial NCT06258837?

The interventions under investigation include: DISE-Directed Surgery (PROCEDURE), Adenotonsillectomy (PROCEDURE).

Who is sponsoring clinical trial NCT06258837?

This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06258837 being conducted?

This trial has 2 study locations across Michigan, Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obstructive Sleep Apnea

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06258837's enrollment target sits among peer trials

240 32nd of 155 higher than 123 of 155 other Obstructive Sleep Apnea trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obstructive Sleep Apnea trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02855554 · 240 participants · NA

    Quantitative Cardiac Parametric Mapping

  • NCT03230565 · 240 participants · Phase 4

    Continuous Infusions vs Scheduled Bolus Infusions

  • NCT03399929 · 240 participants

    Traumatic Brain Injury and Stroke Long Term Outcome

  • NCT03583710 · 240 participants · Phase 3

    Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06258837, the US trial registry maintained by the National Library of Medicine. NCT06258837 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.